EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-Term Outcomes of Epidural Motor Cortex Stimulation for Refractory Chronic Neuropathic Orofacial Pain

Marina Raguž iD, Marko Tarle iD, Petar Marčinković, Sven Krušić iD, Domagoj Dlaka, Tonko Marinović, Darko Chudy

Life · 12.04.2026 · 16 (4) · 651

DOI: 10.3390/life16040651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life, online erschienen am 12.04.2026. Verfasst von Marina Raguž und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Dubrava University Hospital, 10000 Zagreb, Croatia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ERDF fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epidural motor cortex stimulation (MCS) is an established neuromodulatory option for refractory neuropathic pain; however, structured data on long-term outcomes, stimulation dependency, and real-world device management remain limited, particularly in chronic neuropathic orofacial pain.

Methods

This retrospective single-center cohort study included patients with refractory neuropathic orofacial pain treated with epidural MCS at a tertiary neurosurgical center. Clinical data were extracted from medical records and longitudinal follow-up documentation. Pain intensity was assessed using a unified 0–10 numerical rating scale (NRS/VAS) at baseline, best achieved response, and last follow-up. Responder status was defined at the last follow-up (≥50% pain reduction from baseline). Secondary outcomes included stimulation dependency during OFF periods, reprogramming burden, device-related events, and safety.

Results

Ten patients (6 women, 4 men; mean age 61.5 ± 8.6 years) were followed for a mean of 7.6 ± 6.3 years (range 2–22 years), with 70% exceeding five years of follow-up. Baseline pain intensity (8.8 ± 0.4) decreased to 4.6 ± 0.8 at the best achieved response and remained lower at last follow-up (5.6 ± 0.9). At the last follow-up, eight patients (80%) were classified as partial responders (30–49% pain reduction), while two (20%) were classified as non-responders. Clinically relevant worsening during stimulator OFF periods occurred in 70% of patients. Reprogramming was required in all patients, and 60% underwent battery replacement. No clinically significant stimulation-related adverse effects were observed.

Conclusions

Epidural MCS was associated with sustained pain reduction over extended follow-up. These findings support the interpretation of MCS as a chronic neuromodulatory therapy requiring ongoing stimulation, individualized programming, and long-term device management, contributing clinically relevant long-term evidence to the evolving role of neuromodulation in refractory chronic neuropathic pain.

Schlagwörter

Stichwörter der Autor:innen

chronic neuropathic paininvasive neuromodulationlong-term outcomesmotor cortex stimulationneuropathic orofacial painrefractory painstimulation dependency

Autor:innen und Institutionen

  • Department of Neurosurgery, Dubrava University Hospital, 10000 Zagreb, Croatia.
  • School of Medicine, Catholic University of Croatia, 10000 Zagreb, Croatia.
  • Department of Maxillofacial Surgery, Dubrava University Hospital, 10000 Zagreb, Croatia.
  • School of Dental Medicine, University of Zagreb, 10000 Zagreb, Croatia.
  • Medicine of Sports and Exercise Chair, Faculty of Kinesiology, University of Zagreb, 10000 Zagreb, Croatia.
  • School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.

ORCID-Profile: Marina Raguž, Marko Tarle, Sven Krušić

Förderung

  • ERDF fund

Zitieren

APA

Raguž, M., Tarle, M., Marčinković, P., Krušić, S., Dlaka, D., Marinović, T., & Chudy, D. (2026). Long-Term Outcomes of Epidural Motor Cortex Stimulation for Refractory Chronic Neuropathic Orofacial Pain. Life, 16(4), 651. https://doi.org/10.3390/life16040651

Vancouver

Raguž M, Tarle M, Marčinković P, Krušić S, Dlaka D, Marinović T, et al. Long-Term Outcomes of Epidural Motor Cortex Stimulation for Refractory Chronic Neuropathic Orofacial Pain. Life. 2026;16(4):651. doi:10.3390/life16040651

BibTeX
@article{Ragu2026,
  author = {Raguž, Marina and Tarle, Marko and Marčinković, Petar and Krušić, Sven and Dlaka, Domagoj and Marinović, Tonko and Chudy, Darko},
  title = {Long-Term Outcomes of Epidural Motor Cortex Stimulation for Refractory Chronic Neuropathic Orofacial Pain},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {4},
  pages = {651},
  doi = {10.3390/life16040651}
}
Kostenlos starten →